219 related articles for article (PubMed ID: 24612661)
1. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.
Blazeby JM; Hall E; Aaronson NK; Lloyd L; Waters R; Kelly JD; Fayers P
Eur Urol; 2014 Dec; 66(6):1148-56. PubMed ID: 24612661
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24.
Park J; Shin DW; Kim TH; Jung SI; Nam JK; Park SC; Hong S; Jung JH; Kim H; Kim WT
Cancer Res Treat; 2018 Jan; 50(1):40-49. PubMed ID: 28279061
[TBL] [Abstract][Full Text] [Related]
3. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
[TBL] [Abstract][Full Text] [Related]
4. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.
Ripping TM; Westhoff E; Aaronson NK; Van Hemelrijck M; Rammant E; Witjes JA; Kiemeney LA; Aben KKH; Vrieling A
J Patient Rep Outcomes; 2021 Sep; 5(1):96. PubMed ID: 34542736
[TBL] [Abstract][Full Text] [Related]
5. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
7. The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.
Rammant E; Fox L; Beyer K; Aaronson NK; Chaloner R; De Padova S; Liedberg F; Wintner LM; Decaestecker K; Fonteyne V; Perdek N; Wylie H; Catto JWF; Ripping TM; Holzner B; Van Leeuwen M; Van Hemelrijck M;
Qual Life Res; 2023 Aug; 32(8):2127-2135. PubMed ID: 36648569
[TBL] [Abstract][Full Text] [Related]
8. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
[TBL] [Abstract][Full Text] [Related]
9. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
[TBL] [Abstract][Full Text] [Related]
10. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
Greimel E; Nagele E; Lanceley A; Oberguggenberger AS; Nordin A; Kuljanic K; Arraras JI; Wei-Chu C; Jensen PT; Tomaszewski KA; Creutzberg CL; Galalae R; Toelen H; Zimmermann K; Bjelic-Radisic V; Costantini A; Almont T; Serpentini S; Paskeviciute Frøding L; Vistad I; Schmalz C;
Eur J Cancer; 2021 Sep; 154():235-245. PubMed ID: 34298374
[TBL] [Abstract][Full Text] [Related]
11. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
12. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
[TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
14. A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.
Sanna B; Bereza K; Paradowska D; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Golec J; Bottomley A; Tomaszewski KA
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28497549
[TBL] [Abstract][Full Text] [Related]
15. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
16. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
[TBL] [Abstract][Full Text] [Related]
17. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Sprangers MA; te Velde A; Aaronson NK
Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
[TBL] [Abstract][Full Text] [Related]
18. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
[TBL] [Abstract][Full Text] [Related]
19. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
[TBL] [Abstract][Full Text] [Related]
20. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients.
Arraras JI; Villafranca E; Arias de la Vega F; Romero P; Rico M; Vila M; Asín G; Chicata V; Domínguez MA; Lainez N; Manterola A; Martínez E; Martínez M
Clin Transl Oncol; 2009 Mar; 11(3):160-4. PubMed ID: 19293053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
